Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
9
Frequently Asked Questions
What is Market Cap of Alterity Therapeutics Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alterity Therapeutics Ltd - ADR market cap is $74.9M.
What is the 52-week high for Alterity Therapeutics Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alterity Therapeutics Ltd - ADR 52 week high is $7.00 as of September 16, 2025.
What is the 52-week low for Alterity Therapeutics Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alterity Therapeutics Ltd - ADR 52 week low is $1.00 as of September 16, 2025.
What is Alterity Therapeutics Ltd - ADR stock price today?
Alterity Therapeutics Ltd - ADR stock price today is $4.64.
What was Alterity Therapeutics Ltd - ADR stock price yesterday?
Alterity Therapeutics Ltd - ADR stock price yesterday was $4.88.
What is the PE ratio of Alterity Therapeutics Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alterity Therapeutics Ltd - ADR’s P/E ratio is -6.55.
What is the Price-to-Book ratio of Alterity Therapeutics Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alterity Therapeutics Ltd - ADR P/B ratio is 2.6714.
What is the 50-day moving average of Alterity Therapeutics Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alterity Therapeutics Ltd - ADR 50-day moving average is $5.00.
How many employess does Alterity Therapeutics Ltd - ADR has?